OCTOBER - 20206October 2020, volume 04 - Issue 17 Published by ValleyMedia, Inc. Managing EditorAlex D'souzaEditorial StaffVisualizerJohn GothamSalesAndrew D'Souzaandrew.dsouza@medicaltechoutlook.com510.996.5123Contact usEmailPhone:510 230 0396 Fax:510-894-8405sales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comJoshua Parker Merlin WatsonJoe Philip Laura PintoTo subscribe to MedicalTech OutlookVisit www.medicaltechoutlook.com Copyright © 2020 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffAlex D'souzaManaging Editoreditor@Medicaltechoutlook.comIn vitro diagnostic solutions involve medical devices and consumables that are utilized to perform in vitro tests on various biological samples. These help in the diagnosis of various illnesses such as diabetes, cancer, etc. And with the high prevalence of chronic and infectious diseases, the global in vitro diagnostic market is expected to grow with a CAGR of 4.81 percent. The current growth can also be attributed to the recent technological advancements in in-vitro diagnostic devices, which have overcome previous limitations and created increased efficiency. In the product segment of the in vitro diagnostic solutions, the reagent--which includes chemical, biological, and immunological components--has the largest market size. These reagents are used in devices to diagnose, analyse, and monitor a patient's health conditions. Further, many companies are directing their efforts to develop newer concepts and theories for diagnosing chronic ailments and other diseases using in vitro diagnostic solutions. The advancements in in-vitro diagnostic solutions have had positive impact on end users due to portable diagnostic kits, which is preferred by many geriatric patients. In this edition of MedTech Outlook, we bring you the story of some of the most successful in vitro diagnostic solution providers that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership from subject matter experts with real-life stories on fostering robust partnerships and exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing the cloud solution providers according to your requirements.Let us know your thoughts!Paradigm Shift to New Generation DiagnosticsSarah FernandesEDITORIAL
< Page 5 | Page 7 >